Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria

Tomas Majtan, Wendell Jones, Jakub Krijt, Insun Park, Warren D. Kruger, Viktor Kožich, Steven Bassnett, Erez M. Bublil, Jan P. Kraus

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Classical homocystinuria (HCU) is the most common inherited disorder of sulfur amino acid metabolism caused by deficiency in cystathionine beta-synthase (CBS) activity and characterized by severe elevation of homocysteine in blood and tissues. Treatment with dietary methionine restriction is not optimal, and poor compliance leads to serious complications. We developed an enzyme replacement therapy (ERT) and studied its efficacy in a severe form of HCU in mouse (the I278T model). Treatment was initiated before or after the onset of clinical symptoms in an effort to prevent or reverse the phenotype. ERT substantially reduced and sustained plasma homocysteine concentration at around 100 μM and normalized plasma cysteine for up to 9 months of treatment. Biochemical balance was also restored in the liver, kidney, and brain. Furthermore, ERT corrected liver glucose and lipid metabolism. The treatment prevented or reversed facial alopecia, fragile and lean phenotype, and low bone mass. In addition, structurally defective ciliary zonules in the eyes of I278T mice contained low density and/or broken fibers, while administration of ERT from birth partially rescued the ocular phenotype. In conclusion, ERT maintained an improved metabolic pattern and ameliorated many of the clinical complications in the I278T mouse model of HCU. Majtan et al. studied efficacy of a novel enzyme replacement therapy for homocystinuria using transgenic mouse model with a severe form of the disease. The treatment maintained and improved metabolic balance in the face of an unrestricted diet and ameliorated multitude of clinical symptoms, including the disease-characteristic ocular phenotype.

Original languageEnglish
Pages (from-to)834-844
Number of pages11
JournalMolecular Therapy
Volume26
Issue number3
DOIs
StatePublished - Mar 7 2018

Keywords

  • PEGylation
  • alopecia
  • bone density
  • cystathionine beta-synthase
  • enzyme replacement
  • eye defect
  • homocysteine
  • inborn error of metabolism
  • metabolomics
  • preclinical studies

Fingerprint Dive into the research topics of 'Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria'. Together they form a unique fingerprint.

  • Cite this

    Majtan, T., Jones, W., Krijt, J., Park, I., Kruger, W. D., Kožich, V., Bassnett, S., Bublil, E. M., & Kraus, J. P. (2018). Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Molecular Therapy, 26(3), 834-844. https://doi.org/10.1016/j.ymthe.2017.12.014